TPEX/6734 (TPEX/6734)

Taipei Exchange: TPEX/6734 · TWD

NT$7.85

+1.75 (+28.7%)· Recorded snapshot

Market cap	303.9M
Revenue (ttm)	26.7M
Net income (ttm)	-49.1M
EPS (ttm)	-NT$1.25
Shares out	40.6M
Volume	1,622,600
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.7M
Net income (ttm): -49.1M
EPS (ttm): -NT$1.25
Market cap: 303.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-14 02:00 UTC

Forward P/En/a

P25 12.6P50 19.6P75 33.7

Trailing P/En/a

P25 12.4P50 16.1P75 31.9

ROEn/a

P25 -13.1P50 1.6P75 11.6

ROIC-88.2

P25 -10.7P50 -0.8P75 8.4

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All TPEX/6734 indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

TWD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 312.6M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Industry PE	34.94
Isin	TW0006734007
Last refreshed	2026-09-14
Market cap	TWD 303.9M
Price	TWD 7.85
Price currency	TWD
Sector	Healthcare
Sector PE	86.1
Sector PE Fwd	26.83
Sic	3845
Symbol	tpex/6734
Website	https://www.ixensor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.16%
EV/Sales	11.72x
FCF yield	-15.95%
P/B ratio	35.37x
P/S ratio	11.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-181.3%
EBITDA Margin	-173.11%
Gross margin	60.41%
Gross Profit	TWD 16.1M
Gross Profit Growth	55.4%
Gross Profit Growth Q	-15.15%
Gross Profit Growth3 Y	9.01%
Gross Profit Growth5 Y	53.78%
Net Income	TWD -49.1M
Net Income Growth Years	0%
Pretax Margin	-184.11%
Profit Margin	-184.11%
ROA	-66.66
Roa5y	-35.18
ROCE	-291.2
Roe5y	-145.6
ROIC	-88.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-0.38%
Cagr3y	-27.81%
Cagr5y	-26.79%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	8.46x
Revenue Growth Q	-1.71x
Revenue Growth Qo Q	-14.09x
Revenue Growth Years	1x
Revenue Growth3 Y	-10.61x
Revenue Growth5 Y	13.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.59
Assets	TWD 46.3M
Cash	TWD 18.7M
Current Assets	TWD 34.9M
Current Liabilities	TWD 29.7M
Debt	TWD 27.5M
Debt Equity	TWD 3.2
Debt FCF	TWD -0.57
Equity	TWD 8.6M
Interest Coverage	-49.64
Liabilities	TWD 37.7M
Long Term Assets	TWD 11.4M
Long Term Liabilities	TWD 8M
Net Cash	TWD -8.7M
Net Cash By Market Cap	TWD -2.87
Net Debt Equity	TWD 1.02
Tangible Book Value	TWD 2.5M
Tangible Book Value Per Share	TWD 0.06
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Inventory Turnover	1.42
Net Working Capital	TWD 5.9M
Quick ratio	0.83
Working Capital	TWD 5.2M
Working Capital Turnover	TWD -2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-44.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-0.38%
200-day SMA	6.74
3Y total return	-62.39%
50-day SMA	6.44
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.96%
All Time High	120
All Time High Change	-93.46%
All Time High Date	2020-05-26
All Time Low	3.86
All Time Low Change	103.37%
All Time Low Date	2024-11-25
ATR	0.62
Beta	0.57
Beta1y	0.64
Beta2y	0.41
Ch YTD	34.19
High	7.9
High52	18.5
High52 Date	2026-01-30
High52ch	-57.57%
Low	5.7
Low52	4.71
Low52 Date	2026-04-08
Low52ch	66.67%
Ma50ch	21.89%
Price vs 200-day SMA	16.54%
RSI	64.87
RSI Monthly	43.11
RSI Weekly	55.45
Sharpe ratio	0.49x
Sharpe Ratio3y	0.01x
Sharpe Ratio5y	-0.09x
Sortino ratio	1.03
Sortino Ratio3y	0.09
Sortino Ratio5y	-0.07
Total Return	-44.8%
Tr YTD	34.19
Tr1m	22.47%
Tr1w	40.18%
Tr3m	15.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,642,792%
Net Borrowing	-20,550,000
Shares Insiders	7.99%
Shares Institutions	11.43%
Shares Out	40,623,000
Shares Qo Q	7%
Shares Yo Y	44.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -48.5M
Adjusted OCF	-48,300,000
Average Volume	163,243.55x
Bv Per Share	0.21
CAPEX	TWD -168,000
Ch1m	22.47
Ch1w	40.18
Ch1y	-0.38
Ch3m	15.78
Ch3y	-64.92
Ch5y	-80.38
Ch6m	13.93
Change	28.69%
Change From Open	27.85
Close	6.1
Days Gap	0.66
Depreciation Amortization	2,184,000
Dollar Volume	12,737,410
Earnings Date	2026-11-13
EBIT	TWD -48.3M
EBITDA	TWD -46.2M
EPS	TWD -1.25
F Score	4
FCF	TWD -48.5M
FCF EV Yield	-15.5x
FCF Per Share	TWD -1.19
Financing CF	53,311,000
Fiscal Year End	December
Founded	2,012
Investing CF	411,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Last Split Date	2024-08-22
Last Split Type	Reverse
Ma150	6.9
Ma150ch	13.77%
Ma20	6.11
Ma20ch	28.52%
Net CF	5,419,000
Next Earnings Date	2026-11-13
Open	6.14
Position In Range	97.73
Ppne	4,148,000
Price Date	2026-09-11
Ptbv Ratio	121.9
Relative Volume	20.32x
Revenue	26,667,000x
SBC By Revenue	0.04x
Share Based Comp	11,000
Tr6m	13.93%
Volume	1,622,600
Z Score	-13.87

Deeper analysis on TPEX/6734

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this TPEX/6734 report

Is a complete TPEX/6734 research report available?

No complete published report is available for tpex/6734 (TPEX/6734) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6734 (TPEX/6734)

Taipei Exchange: TPEX/6734 · TWD

NT$7.85

+1.75 (+28.7%)· Recorded snapshot

Market cap	303.9M
Revenue (ttm)	26.7M
Net income (ttm)	-49.1M
EPS (ttm)	-NT$1.25
Shares out	40.6M
Volume	1,622,600
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.7M
Net income (ttm): -49.1M
EPS (ttm): -NT$1.25
Market cap: 303.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-14 02:00 UTC

Forward P/En/a

P25 12.6P50 19.6P75 33.7

Trailing P/En/a

P25 12.4P50 16.1P75 31.9

ROEn/a

P25 -13.1P50 1.6P75 11.6

ROIC-88.2

P25 -10.7P50 -0.8P75 8.4

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All TPEX/6734 indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

TWD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 312.6M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Industry PE	34.94
Isin	TW0006734007
Last refreshed	2026-09-14
Market cap	TWD 303.9M
Price	TWD 7.85
Price currency	TWD
Sector	Healthcare
Sector PE	86.1
Sector PE Fwd	26.83
Sic	3845
Symbol	tpex/6734
Website	https://www.ixensor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.16%
EV/Sales	11.72x
FCF yield	-15.95%
P/B ratio	35.37x
P/S ratio	11.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-181.3%
EBITDA Margin	-173.11%
Gross margin	60.41%
Gross Profit	TWD 16.1M
Gross Profit Growth	55.4%
Gross Profit Growth Q	-15.15%
Gross Profit Growth3 Y	9.01%
Gross Profit Growth5 Y	53.78%
Net Income	TWD -49.1M
Net Income Growth Years	0%
Pretax Margin	-184.11%
Profit Margin	-184.11%
ROA	-66.66
Roa5y	-35.18
ROCE	-291.2
Roe5y	-145.6
ROIC	-88.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-0.38%
Cagr3y	-27.81%
Cagr5y	-26.79%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	8.46x
Revenue Growth Q	-1.71x
Revenue Growth Qo Q	-14.09x
Revenue Growth Years	1x
Revenue Growth3 Y	-10.61x
Revenue Growth5 Y	13.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.59
Assets	TWD 46.3M
Cash	TWD 18.7M
Current Assets	TWD 34.9M
Current Liabilities	TWD 29.7M
Debt	TWD 27.5M
Debt Equity	TWD 3.2
Debt FCF	TWD -0.57
Equity	TWD 8.6M
Interest Coverage	-49.64
Liabilities	TWD 37.7M
Long Term Assets	TWD 11.4M
Long Term Liabilities	TWD 8M
Net Cash	TWD -8.7M
Net Cash By Market Cap	TWD -2.87
Net Debt Equity	TWD 1.02
Tangible Book Value	TWD 2.5M
Tangible Book Value Per Share	TWD 0.06
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Inventory Turnover	1.42
Net Working Capital	TWD 5.9M
Quick ratio	0.83
Working Capital	TWD 5.2M
Working Capital Turnover	TWD -2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-44.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-0.38%
200-day SMA	6.74
3Y total return	-62.39%
50-day SMA	6.44
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.96%
All Time High	120
All Time High Change	-93.46%
All Time High Date	2020-05-26
All Time Low	3.86
All Time Low Change	103.37%
All Time Low Date	2024-11-25
ATR	0.62
Beta	0.57
Beta1y	0.64
Beta2y	0.41
Ch YTD	34.19
High	7.9
High52	18.5
High52 Date	2026-01-30
High52ch	-57.57%
Low	5.7
Low52	4.71
Low52 Date	2026-04-08
Low52ch	66.67%
Ma50ch	21.89%
Price vs 200-day SMA	16.54%
RSI	64.87
RSI Monthly	43.11
RSI Weekly	55.45
Sharpe ratio	0.49x
Sharpe Ratio3y	0.01x
Sharpe Ratio5y	-0.09x
Sortino ratio	1.03
Sortino Ratio3y	0.09
Sortino Ratio5y	-0.07
Total Return	-44.8%
Tr YTD	34.19
Tr1m	22.47%
Tr1w	40.18%
Tr3m	15.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,642,792%
Net Borrowing	-20,550,000
Shares Insiders	7.99%
Shares Institutions	11.43%
Shares Out	40,623,000
Shares Qo Q	7%
Shares Yo Y	44.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -48.5M
Adjusted OCF	-48,300,000
Average Volume	163,243.55x
Bv Per Share	0.21
CAPEX	TWD -168,000
Ch1m	22.47
Ch1w	40.18
Ch1y	-0.38
Ch3m	15.78
Ch3y	-64.92
Ch5y	-80.38
Ch6m	13.93
Change	28.69%
Change From Open	27.85
Close	6.1
Days Gap	0.66
Depreciation Amortization	2,184,000
Dollar Volume	12,737,410
Earnings Date	2026-11-13
EBIT	TWD -48.3M
EBITDA	TWD -46.2M
EPS	TWD -1.25
F Score	4
FCF	TWD -48.5M
FCF EV Yield	-15.5x
FCF Per Share	TWD -1.19
Financing CF	53,311,000
Fiscal Year End	December
Founded	2,012
Investing CF	411,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Last Split Date	2024-08-22
Last Split Type	Reverse
Ma150	6.9
Ma150ch	13.77%
Ma20	6.11
Ma20ch	28.52%
Net CF	5,419,000
Next Earnings Date	2026-11-13
Open	6.14
Position In Range	97.73
Ppne	4,148,000
Price Date	2026-09-11
Ptbv Ratio	121.9
Relative Volume	20.32x
Revenue	26,667,000x
SBC By Revenue	0.04x
Share Based Comp	11,000
Tr6m	13.93%
Volume	1,622,600
Z Score	-13.87

Deeper analysis on TPEX/6734

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this TPEX/6734 report

Is a complete TPEX/6734 research report available?

No complete published report is available for tpex/6734 (TPEX/6734) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6734 (TPEX/6734)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6734

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6734 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6734

Frequently asked questions

TPEX/6734 (TPEX/6734)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6734

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6734 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6734

Frequently asked questions